drugset / Trial / NCT04705922

Relative Bioavailability Study and Food Effect Study of TT-00420 (Tinengotinib) Capsule and Tablet Formulations in Healthy Volunteers

NCT04705922

Phase 1 Completed 24 enrolled TransThera Sciences (Nanjing), Inc.
RandomizedCrossoverOpen-labelOther

Summary

This study is an open-label, 3-way crossover randomized study in adult healthy volunteers to evaluate the relative bioavailability of TT-00420 tablet and capsule formulations and to evaluate food effect on the pharmacokinetics of TT-00420 tablet.

Timeline

Start
2020-12-29
Primary completion
2021-03-07
Completion
2021-07-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Tinengotinib Small molecule Oral

Indications

No indication recorded.